KENNEDY INVESTMENT GROUP, INC.

Position in LLY — ELI LILLY & Co

CIK 1978005 WEST DEPTFORD, NJ

Position in LLY

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$3,291,236

+$874,081 QoQ

Shares Held

2,744

+4.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.62%

of 13F equity value

Holder Rank

#2,043

of 4,605 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

KENNEDY INVESTMENT GROUP, INC. holds $14,260,907 across 7 Drug Manufacturers - General names. LLY ranks #3 (23.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	15,754	$3,964,336
2	NVO	Novo Nordisk A S	69,531	$3,333,316
3	LLY	ELI LILLY & Co This page	2,744	$3,291,236
4	JNJ	Johnson & Johnson	6,591	$1,673,916
5	NVS	Novartis AG	5,972	$935,931
6	AMGN	Amgen Inc	1,946	$704,685
7	MRK	Merck & Co., Inc.	2,782	$357,487

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,291,236	2,744	+4.4%	Shares	Sole	2026-07-30
2026-03-31	$2,417,155	2,628	-1.6%	Shares	Sole	2026-04-22
2025-12-31	$2,870,470	2,671	-4.3%	Shares	Sole	2026-02-06
2025-09-30	$2,130,296	2,792	+0.3%	Shares	Sole	2025-10-28
2025-06-30	$2,169,431	2,783	-1.7%	Shares	Sole	2025-07-16
2025-03-31	$2,338,977	2,832	+11.1%	Shares	Sole	2025-04-22
2024-12-31	$1,967,828	2,549	+22.7%	Shares	Sole	2025-01-22
2024-09-30	$1,840,097	2,077	+11.1%	Shares	Sole	2024-10-21
2024-06-30	$1,692,155	1,869	+2.6%	Shares	Sole	2024-07-18
2024-03-31	$1,416,665	1,821	+19.8%	Shares	Sole	2024-04-22
2023-12-31	$886,038	1,520	+15.3%	Shares	Sole	2024-01-29
2023-09-30	$707,937	1,318	-1.3%	Shares	Sole	2023-10-25
2023-06-30	$626,557	1,336	-0.4%	Shares	Sole	2023-07-19
2023-03-31	$460,526	1,341	-3.2%	Shares	Sole	2023-06-01
2022-12-31	$507,054	1,386	—	Shares	Sole	2023-06-01
No filing history on record for this holder in this stock.